NCT03438305

Brief Summary

Background :An important risk factor for aspiration is gastric volume, determined in large part by gastric emptying. Unfortunately, measuring gastric volume over time is not easy, and scintigraphy has remained the gold standard technique for many years. Ultrasound has progressively emerged as a useful substitute due to its reduced cost and ease of performance Objectives:Assess whether ultrasonographic measurement of antral cross sectional area (CSA) can be used reliably for the diagnosis of risk stomach which defined by a gastric content volume at risk of clinical consequences for pulmonary aspiration (i.e., presence of solid particles and/or gastric fluid volume \>1.5 ml/kg) during the preoperative period in longstanding diabetic patients. Study population :

  • -Longstanding diabetic patients (group D)
  • -Non diabetic patients (group N) Study Design : Prospective observational study This study will be conducted at Kasr alainy Hospital; Faculty of Medicine, Cairo University.Patients scheduled for elective operations need General Anesthesia (GA) with endotracheal intubation in theatre of general surgery Preoperative ultrasound to assess gastric residual volume then general anesthesia induction will be Modified Rapid-sequence Induction as follow; Group (D)/(N) : propofol 2-3mg/kg and fentanyl 1 µg/Kg followed by Rocuronium 0.6-1.2 mg/kg. Suction of Gastric Contents by Nasogastric tube (18 french) will be inserted First set of analysis will be comparing preoperative US findings in 2 groups. Second set of analysis will be finding correlation between US findings and suction volume in two groups. Outcome parameters: To assess the residual gastric volume in longstanding diabetic patients compared to non diabetic patients. Sample Size ; was calculated as 48 patients (24) in each group.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

February 19, 2018

Status Verified

February 1, 2018

Enrollment Period

3 months

First QC Date

February 12, 2018

Last Update Submit

February 16, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • assessment of residual gastric volume in longstanding diabetic patients

    To assess the residual gastric volume in longstanding diabetic patients compared to non diabetic patients

    intra-operative

Secondary Outcomes (1)

  • correlation between preoperative gastric US findings and fasting hours in both groups

    intraoperative

Study Arms (2)

Group D

Other: sonar assessment of gastric volume in Diabetic patients

Group N

Other: sonar assessment of gastric volume in Non Diabetic patients

Interventions

assessment of gastric volume in Diabetic Patients

Group D

assessment of gastric volume in Non- Diabetic Patients

Group N

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Diabetic patients with long standing diabetis ( more than 6 years) so , it may affect gastric nerve supply.

You may qualify if:

  • Ages from 40 to 60 years old.
  • American Society of Anesthiologist (ASA) II.
  • Diabetic patients with longstanding duration(more than 6 years).

You may not qualify if:

  • Age \<40,\>60 years .
  • Pregnant female
  • Obese patients (BMI ≤40)
  • Patients with Gastric Intestinal Tract (GIT) diseases affect gastric emptying.
  • Diabetic patients less than 6 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Sabry R, Hasanin A, Refaat S, Abdel Raouf S, Abdallah AS, Helmy N. Evaluation of gastric residual volume in fasting diabetic patients using gastric ultrasound. Acta Anaesthesiol Scand. 2019 May;63(5):615-619. doi: 10.1111/aas.13315. Epub 2019 Jan 4.

MeSH Terms

Conditions

Gastroparesis

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthiology

Study Record Dates

First Submitted

February 12, 2018

First Posted

February 19, 2018

Study Start

March 1, 2018

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

February 19, 2018

Record last verified: 2018-02